Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 3, 2008 - Issue 2
Submit an article Journal homepage
588
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Vitamin D in the treatment and prevention of tuberculosis

Adrian R Martineau Centre for Health Sciences, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. [email protected]
,
Christopher J Griffiths Centre for Health Sciences, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK
&
Robert J Wilkinson National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK; and Division of Medicine, Imperial College, London W2 1PG, UK; and Institute of Infectious Diseases and Molecular Medicine and Department of Medicine, University of Cape Town, Observatory 7925, South Africa
Pages 105-107 | Published online: 10 Jan 2014

References

  • Maartens G, Wilkinson RJ. TB. Lancet370(9604), 2030–2043 (2007).
  • WHO. Global TB control: surveillance, planning, and financing. WHO Report 2007. Geneva, Switzerland (2007).
  • Chapman HT. On the use of cod-liver oil in diseases of the bones and joints, in consumption and in other maladies attended by great emaciation. Phamaceutical Transactions1–16 (1849).
  • Charpy J. Quelques traitments vitaminés ou par substances fonctionelles en dermatologie. Bull. Méd.24, 505 (1950).
  • Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary TB. J. Steroid Biochem. Mol. Biol.103, 793–798 (2007).
  • Davies PD. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle66(4), 31–36 (1985).
  • Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on TB among Gujarati Asians in west London: a case-control study. Lancet355(9204), 618–621 (2000).
  • Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med.176(2), 8–13 (2000).
  • Crowle AJ, Ross EJ, May MH. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun.55(12), 2945–2950 (1987).
  • Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov.3(1), 27–41 (2004).
  • Martineau AR, Wilkinson KA, Newton SM et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol.178(11), 7190–7198 (2007).
  • Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol.173(5), 2909–2912 (2004).
  • Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science311(5768), 1770–1773 (2006).
  • Martineau AR, Newton SM, Wilkinson KA et al. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest.117(7), 1988–1994 (2007).
  • Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium TB is dependent on the induction of cathelicidin. J. Immunol.179(4), 260–263 (2007).
  • Vieth R, McCarten K, Norwich KH. Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production. Am. J. Physiol.258(5 Pt 1), E780–E789 (1990).
  • Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am. J. Clin. Nutr.69, 842–856 (1999).
  • Morcos MM, Gabr AA, Samuel S et al. Vitamin D administration to tuberculous children and its value. Boll. Chim. Farm.137(5)1, 57–64 (1998).
  • Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones.38(1), 3–5 (2006).
  • Mitchison DA. The diagnosis and therapy of TB during the past 100 years. Am. J. Respir. Crit. Care Med.171(7), 699–706 (2005).
  • Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary TB by culture at 2 months. Am. Rev. Respir. Dis.147(4), 162–163 (1993).
  • Feeny PJ. Calciferol in TB. Lancet438–443 (1947).
  • Kimball SM, Ursell MR, O’Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am. J. Clin. Nutr.86(3), 645–651 (2007).
  • Narang NK, Gupta RC, Jain MK. Role of vitamin D in pulmonary TB. J. Assoc. Physicians India32(2), 185–188 (1984).
  • Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin. Trials18, 274 (1997).
  • Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int.16(7), 713–716 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.